U.S. makes deal for 100 million doses of coronavirus vaccine

Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation’s top health agency predicted that fatalities would rise in the coming weeks.

“Today’s investment supports our latest vaccine candidate, an adjuvanted product being developed by Sanofi and GSK, all the way through clinical trials and manufacturing, with the potential to bring hundreds of millions of safe and effective doses to the American people,” Alex Azar, secretary of the U.S. Department of Health and Human Services, said in announcing the deal.